Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. [electronic resource]
Producer: 19971009Description: 299-312 p. digitalISSN:- 0902-0063
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Azathioprine -- therapeutic use
- Bone Marrow Transplantation
- Case-Control Studies
- Cyclosporine -- adverse effects
- Diabetes Mellitus -- chemically induced
- Diabetes Mellitus, Type 1 -- chemically induced
- Female
- Follow-Up Studies
- Gastrointestinal Diseases -- chemically induced
- Graft Rejection -- drug therapy
- Graft Survival
- Humans
- Immunosuppressive Agents -- administration & dosage
- Incidence
- Kidney Diseases -- chemically induced
- Kidney Transplantation
- Lymphoma -- chemically induced
- Male
- Muromonab-CD3 -- therapeutic use
- Mycophenolic Acid -- analogs & derivatives
- Nervous System Diseases -- chemically induced
- Pancreas Transplantation -- adverse effects
- Prednisone -- therapeutic use
- Prospective Studies
- Randomized Controlled Trials as Topic
- Survival Rate
- Tacrolimus -- administration & dosage
- Transplantation, Homologous
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.